Azienda ospedaliero-universitaria San Luigi Gonzaga di Orbassano (Torino)

Borsa di studio “Non-interventional Post-Authorization Safety Study (PASS) to Prospectively Evaluate Rebif New Formulation Safety and Tolerability Profile In Treatment of Naïve Relapsing Sclerosin Patients”. Avviso di rettifica.

Testo del documento